LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine

被引:5
|
作者
Baldi, Simona
Frascerra, Silvia
Ferrannini, Ele
Natali, Andrea
机构
[1] Univ Pisa, Sch Med, Dept Internal Med, I-56100 Pisa, Italy
[2] Univ Pisa, Sch Med, CNR, Inst Clin Physiol, I-56100 Pisa, Italy
关键词
LDL oxidation; lag phase; HDL oxidation; anti-oxidants;
D O I
10.1016/j.cca.2006.12.019
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although LDL resistance to copper-induced oxidation is a time-honoured method, how it is modulated by the physiologic variability of lipid phenotype and what influences the protective action of homologous HDL and exogenous alanine is still unclear. Methods: In 159 subjects without severe dyslipidemias, LDL resistance to copper-induced oxidation (lag phase) was measured under standardised conditions, with alanine and with autologous HDL. Results: Lag phase was normally distributed and averaged 68 +/- 10 min (range: 40-105 min). Both VLDL-triglycerides (37 +/- 5, 52 +/- 7, 59 +/- 7, 53 +/- 5 mg/dl, p<0.05) and LDL-triglycerides (27 +/- 2, 27 +/- 1, 30 +/- 2, 35 +/- 3 mg/dl, p<0.01) increased across quartiles of lag phase. The relative LDL enrichment in triglycerides (triglycerides percent or triglycerides/cholesterol ratio) was strongly related to lag phase (r=0.29 and r=0.31, p<0.0005 for both) independently of age, gender, BMI, and presence of diabetes or hypertension. The protective effect of HDL was variable (+42 +/- 18 min) and largely dependent on the capacity of HDL to resist oxidation (r=0.69,p<0.0001). Alanine induced a rather constant lag phase prolongation (+32 +/- 7 min) that was weakly related only to baseline lag phase (r=0.17,p<0.05). Conclusions: Relative triglyceride abundance protects LDL from ex-vivo oxidation, HDL particles protect LDL mainly through substrate dilution and alanine probably through a direct anti-oxidant effect. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
  • [31] LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure
    Jurek, A
    Turyna, B
    Kubit, P
    Klein, A
    CLINICAL BIOCHEMISTRY, 2006, 39 (01) : 19 - 27
  • [32] Oxidative Modification and Poor Protective Activity of HDL on LDL Oxidation in Thalassemia
    Unchern, Supeenun
    Laohareungpanya, Narumon
    Sanvarinda, Yupin
    Pattanapanyasat, Kovit
    Tanratana, Pansakorn
    Chantharaksri, Udom
    Sibmooh, Nathawut
    LIPIDS, 2010, 45 (07) : 627 - 633
  • [33] HDL capacity to inhibit LDL oxidation in well-trained triathletes
    Brites, Fernando
    Zago, Valenia
    Verona, Julian
    Muzzio, Maria Luz
    Wikinski, Regina
    Schreier, Laura
    LIFE SCIENCES, 2006, 78 (26) : 3074 - 3081
  • [34] The inhibition of LDL oxidation by HDL is not related to their antioxidant content or paraoxonase activity
    Vassanelli, C
    Gilodi, R
    Paffoni, P
    Bagnati, M
    Perugini, C
    Bellomo, G
    EUROPEAN HEART JOURNAL, 2000, 21 : 275 - 275
  • [35] JOINT EFFECTS OF SERUM TRIGLYCERIDES AND LDL AND HDL CHOLESTEROL
    AVINS, AL
    HULLEY, SB
    CIRCULATION, 1993, 87 (01) : 300 - 301
  • [36] Vitamin C inhibits lipid oxidation in human HDL
    Hillstrom, RJ
    Yacapin-Ammons, AK
    Lynch, SM
    JOURNAL OF NUTRITION, 2003, 133 (10): : 3047 - 3051
  • [37] Analyses of LDL and HDL subclasses by a HPLC method: The effects of lipid lowering agents on lipoprotein cholesterol profile.
    Okazaki, M
    Usui, S
    Kazama, H
    Araki, A
    Ito, H
    CLINICAL CHEMISTRY, 2000, 46 (06) : A101 - A101
  • [38] Lipid fluidity at different regions in LDL and HDL of β-thalassemia/Hb E patients
    Morales, Noppawan Phumala
    Charlermchoung, Chalermkhwan
    Luechapudiporn, Rataya
    Yamanont, Paveena
    Fucharoen, Suthat
    Chantharaksri, Udom
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (03) : 698 - 703
  • [39] HDL AND LDL + VLDL CHOLESTEROLS IN SUBJECTS WITH NORMAL BLOOD LIPID-LEVELS
    ROUFFY, J
    CHANU, B
    BAKIR, R
    GOYLOEPER, J
    SAYA, C
    DJIAN, F
    NEEL, D
    TURPIN, E
    GOUSSAULT, Y
    DREUX, C
    NOUVELLE PRESSE MEDICALE, 1981, 10 (22): : 1846 - 1846
  • [40] Lipid transfer mechanism of cholesteryl ester transfer protein between HDL and LDL
    Senapati, Sanjib
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255